V-Tech (Pty) Ltd v South African Health Products Regulatory Authority (2024-008772) [2024] ZAGPPHC 799 (6 August 2024)

V-Tech (Pty) Ltd v South African Health Products Regulatory Authority (2024-008772) [2024] ZAGPPHC 799 (6 August 2024)

The court found that V-Tech failed to establish irreparable harm as required for interim relief. While V-Tech demonstrated inconvenience and potential prejudice due to SAHPRA's enforcement of the import licence requirement, it did not provide detailed facts regarding the nature and extent of harm, loss of revenue, or inability to source APIs from licensed wholesalers. The court noted that V-Tech remained in business months after the enforcement and had used licensed importers, undermining claims of imminent business closure. The absence of primary facts prevented the court from drawing the necessary inference of irreparable harm. Consequently, the application for interim interdict was...

Citation
[2024] ZAGPPHC 799
Parties
Applicant: V-Tech (Pty) Ltd; Respondent: South African Health Products Regulatory Authority
Court
North Gauteng High Court, Pretoria
Jurisdiction
South Africa
Judgment Date
6 August 2024
Case Number
2024-008772
Procedural Posture
Urgent Application / Opposed Motion for Interim Interdict Pending Internal Appeal
Outcome
Application dismissed with costs, including costs of two counsel on Scale B.
Judges
E van der Schyff
Legal Topics
Interim Interdict, Internal Appeal, Licensing of Importers, Medicines and Related Substances Act, Regulatory Authority Powers

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 4 Authorities cited 8 Party arguments 2 Amounts and remedies 2
Sign in to unlock

Parties

V-Tech (Pty) Ltd

Applicant

South African Health Products Regulatory Authority

Respondent

Procedural Posture

Urgent Application / Opposed Motion for Interim Interdict Pending Internal Appeal

  1. 1 Whether V-Tech (Pty) Ltd is entitled to import active pharmaceutical ingredients (APIs) for compounding veterinary medicines without an import licence under section 22C(1)(b) of the Medicines Act.
  2. 2 Whether V-Tech has established a prima facie right to the relief sought.
  3. 3 Whether V-Tech will suffer irreparable harm if interim relief is not granted.

Ratio Decidendi

The court found that V-Tech failed to establish irreparable harm as required for interim relief. While V-Tech demonstrated inconvenience and potential prejudice due to SAHPRA's enforcement of the import licence requirement, it did not provide detailed facts regarding the nature and extent of harm, loss of revenue, or inability to source APIs from licensed wholesalers. The court noted that V-Tech remained in business months after the enforcement and had used licensed importers, undermining claims of imminent business closure. The absence of primary facts prevented the court from drawing the necessary inference of irreparable harm. Consequently, the application for interim interdict was...

Court Disposition

Application dismissed with costs, including costs of two counsel on Scale B.

Orders

  • The application is dismissed with costs, which costs include the costs of two counsel on Scale B.